A double-blind placebo-controlled study with an open-label pilot phase, assessing the efficacy, tolerability and safety of EU-C-001 in patients with moderate to severe traumatic brain injury - PANGEA
100 Clinical Results associated with Eustralis Pharmaceuticals Ltd.
0 Patents (Medical) associated with Eustralis Pharmaceuticals Ltd.
100 Deals associated with Eustralis Pharmaceuticals Ltd.
100 Translational Medicine associated with Eustralis Pharmaceuticals Ltd.